SCHEMBL2856690

SCHEMBL2856690

CN(C)c1n(CCO)cc[n+]1C

nearest known ligand 0.37

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
HDAC8 Q9BY41 3/20 0.32
POLB P06746 1/20 0.31
APOBEC3A P31941 1/20 0.31
CTDSP1 Q9GZU7 1/20 0.31
APOBEC3G Q9HC16 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2869996 0.79 LMNA (0.38) HDAC8POLBAPOBEC3ACTDSP1APOBEC3G
SCHEMBL2865887 0.75
SCHEMBL666878 0.75 CA1 (0.51) CA1CA2HDAC8POLBAPOBEC3A
SCHEMBL2869037 0.74 ACHE (0.34)
Hydrochloric Acid SCHEMBL15318972 0.73 CA1 (0.50) CA1CA2HDAC8
SCHEMBL21490417 0.72 CA1 (0.38) CA1CA2HDAC8APOBEC3AAPOBEC3G
SCHEMBL2869746 0.71 HDAC8 (0.50) HDAC8POLBAPOBEC3ACTDSP1APOBEC3G
SCHEMBL17422678 0.69 CA1 (0.46) CA1CA2HDAC8
SCHEMBL28404964 0.69 CA1 (0.46) CA1CA2HDAC8
SCHEMBL666911 0.65 CA1 (0.42) CA1CA2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12466956-B2 Electroconductive resin composition and molded article of same DENKA COMPANY LIMITED (JP) 2025-11-11 US disclosed
WO-2023189133-A1 CONDUCTIVE RESIN COMPOSITION デンカ株式会社 2023-10-05 WO disclosed
CN-112601786-B Conductive resin composition and molded article thereof 电化株式会社 2023-05-05 CN disclosed
US-20220392373-A1 MUCOSAL TISSUE MODEL DENKA COMPANY LIMITED (JP) 2022-12-08 US disclosed
EP-4083969-A1 MUCOSAL TISSUE MODEL Denka Company Limited (JP) 2022-11-02 EP disclosed
EP-3845600-B1 ELECTROCONDUCTIVE RESIN COMPOSITION AND MOLDED ARTICLE OF SAME DENKA COMPANY LTD (JP) 2022-10-26 EP disclosed
CN-114787895-A Mucosal tissue model 电化株式会社 2022-07-22 CN disclosed
US-20210246314-A1 ELECTROCONDUCTIVE RESIN COMPOSITION AND MOLDED ARTICLE OF SAME DENKA COMPANY LIMITED (JP) 2021-08-12 US disclosed
EP-3845600-A1 ELECTROCONDUCTIVE RESIN COMPOSITION AND MOLDED ARTICLE OF SAME Denka Company Limited (JP) 2021-07-07 EP disclosed
CN-112601786-A Conductive resin composition and molded article thereof 电化株式会社 2021-04-02 CN disclosed
US-7675734-B2 Electrolytic solution and electrolytic capacitor using the same PANASONIC CORPORATION (JP) 2010-03-09 US disclosed
EP-2093191-A1 ACTIVATED CARBON AND METHOD FOR PRODUCING THE SAME Sumitomo Chemical Company, Limited (JP) 2009-08-26 EP disclosed
US-20090161295-A1 ELECTROLYSIS SOLUTION AND ELECTROLYTIC CAPACITOR USING THE SAME SANYO CHEMICAL INDUSTRIES, LTD. (JP) 2009-06-25 US disclosed
US-20090147443-A1 ELECTROLYTIC SOLUTION AND ELECTROLYTIC CAPACITOR USING THE SAME PANASONIC CORPORATION (JP) 2009-06-11 US disclosed
US-20090103241-A1 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-04-23 US disclosed
US-20080316679-A1 Electrolytic Solution for Electrolytic Capacitor, and Electrolytic Capacitor Using the Same PANASONIC CORPORATION (JP) 2008-12-25 US disclosed
US-20080094777-A1 Electric double layer capacitor SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-04-24 US disclosed
EP-1905740-A1 ELECTRIC DOUBLE LAYER CAPACITOR Sumitomo Chemical Company, Limited (JP) 2008-04-02 EP disclosed
EP-1876611-A1 ELECTRIC DOUBLE LAYER CAPACITOR Sumitomo Chemical Company, Limited (JP) 2008-01-09 EP disclosed
EP-1808875-A1 ELECTROLYTE FOR ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR UTILIZING THE SAME MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2007-07-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090103241-A1 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 CBR1, CYP24A1, CALU CA1 58/4885CA2 6/4885HDAC8 2618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.